Het Universitair Ziekenhuis Brussel is het ziekenhuis van de Vrije Universiteit Brussel. Het is verbonden aan de Faculteit Geneeskunde en Farmacie van de VUB en werkt nauw samen met het departement Gezondheidszorg van de Erasmushogeschool Brussel. Deze drie vormen samen met Health City de Medische Campus Jette.

During the past decade, UZ Brussel conducted 468 clinical trials. In the 10-year time frame, 468 clinical trials started and 120 clinical trials were completed, i.e. on average, 25.6% percent of trials that started reached the finish line to date. In the past 5 years, 243 clinical trials started and 86 clinical trials were completed. i.e. 35.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "UZ Brussel" #1 sponsor was "Universitair Ziekenhuis Brussel" with 176 trials, followed by "European Organisation for Research and Treatment of Cancer - EORTC" with 25 trials sponsored, "Hoffmann-La Roche" with 22 trials sponsored, "Vrije Universiteit Brussel" with 18 trials sponsored and "Boehringer Ingelheim" with 18 trials sponsored. Other sponsors include 352 different institutions and companies that sponsored additional 188 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "UZ Brussel" #1 collaborator was "Universitair Ziekenhuis Brussel" with 20 trials as a collaborator, "Vrije Universiteit Brussel" with 9 trials as a collaborator, "University Hospital, Ghent" with 8 trials as a collaborator, "University Hospital, Antwerp" with 7 trials as a collaborator and "European Organisation for Research and Treatment of Cancer - EORTC" with 5 trials as a collaborator. Other collaborators include 387 different institutions and companies that were collaborators in the rest 313 trials.

According to Clinical.Site data, the most researched conditions in "UZ Brussel" are "Infertility" (20 trials), "Cystic Fibrosis" (18 trials), "Failed Back Surgery Syndrome" (17 trials), "Breast Cancer" (12 trials) and "Crohn Disease" (12 trials). Many other conditions were trialed in "UZ Brussel" in a lesser frequency.

Most popular intervention types in "UZ Brussel" are "Drug" (326 trials), "Other" (131 trials), "Device" (79 trials), "Procedure" (37 trials) and "Diagnostic Test" (34 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (95 trials), "IVA" (12 trials), "radiation therapy" (9 trials), "ELX/TEZ/IVA" (6 trials) and "Gemcitabine" (6 trials). Other intervention names were less common.

The vast majority of trials in "UZ Brussel" are 524 trials for "All" genders, 78 trials for "Female" genders and 13 trials for "Male" genders.

Currently, there are 198 active trials in "UZ Brussel". 10 are not yet recruiting, 136 are recruiting, 50 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 289 completed trials in UZ Brussel, 1 suspended trials, and 48 terminated clinical trials to date.

Out of the total trials that were conducted in UZ Brussel, 32 "Phase 1" clinical trials were conducted, 107 "Phase 2" clinical trials and 196 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 37 trials, and there were also 159 trials that are defined as “Not Applicable".

UZ Brussel has several departments that took part in Clinical trials: "University Hospital Brussels- Diabeteskliniek" - 2 trials, "UZ Brussel - Heart Rhythm Management Center" - 3 trials, "AZ -VUB Dienst Nefrologie" - 2 trials, "Universitair Ziekenhuis Brussel - Geriatrie" - 2 trials